TORII PHARMACEUTICAL CO.,LTD. 4551Short Interest
No institution currently reports a short position of 0.5% or more in TORII PHARMACEUTICAL CO.,LTD. (4551). The last disclosure was on 2022-12-15 (MERRILL LYNCH INTERNATIONAL, 0.49%).
Estimated short interest
0.00%
±0.00%
Estimated position (shares)
0
As of 2026-11-18
Holders (0.5% or more)
0 firms
15 reports
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It also excludes 2 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2018-11-01 |
|---|---|
| Latest disclosure | 2022-12-15 (MERRILL LYNCH INTERNATIONAL, 0.49%) |
| Reporting institutions | 2 firms (15 reports) |
| Peak estimated short interest | 0.60% (2018-11-26, 1 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 1 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- MERRILL LYNCH INTERNATIONAL
0.00%
Estimated short interest, 2026-11-18
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2022-12-15 | MERRILL LYNCH INTERNATIONAL | Position 142,279 shares | Ratio 0.49% | ▼0.02% | Below 0.5% |
| 2019-03-12 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 134,600 shares | Ratio 0.46% | ▼0.13% | Below 0.5% |
Disclosure History 15 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2022-12-15 | MERRILL LYNCH INTERNATIONAL | Position 142,279 shares | Ratio 0.49% | ▼0.02% | Below 0.5% |
| 2022-12-14 | MERRILL LYNCH INTERNATIONAL | Position 147,279 shares | Ratio 0.51% | ▲0.01% | — |
| 2022-12-06 | MERRILL LYNCH INTERNATIONAL | Position 144,479 shares | Ratio 0.50% | ▲0.01% | — |
| 2022-11-18 | MERRILL LYNCH INTERNATIONAL | Position 143,979 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
| 2022-11-17 | MERRILL LYNCH INTERNATIONAL | Position 146,879 shares | Ratio 0.50% | ▼0.01% | — |
| 2022-11-10 | MERRILL LYNCH INTERNATIONAL | Position 147,874 shares | Ratio 0.51% | ▲0.01% | — |
| 2022-11-04 | MERRILL LYNCH INTERNATIONAL | Position 145,774 shares | Ratio 0.50% | ▼0.01% | — |
| 2022-11-01 | MERRILL LYNCH INTERNATIONAL | Position 148,674 shares | Ratio 0.51% | ▲0.01% | — |
| 2022-10-31 | MERRILL LYNCH INTERNATIONAL | Position 146,074 shares | Ratio 0.50% | ▲0.02% | — |
| 2019-03-12 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 134,600 shares | Ratio 0.46% | ▼0.13% | Below 0.5% |
| 2019-02-05 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 171,000 shares | Ratio 0.59% | ▼0.01% | — |
| 2019-01-25 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 172,800 shares | Ratio 0.60% | ▲0.02% | — |
| 2018-12-13 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 169,800 shares | Ratio 0.58% | ▼0.02% | — |
| 2018-11-26 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 174,079 shares | Ratio 0.60% | ▲0.10% | — |
| 2018-11-01 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 145,000 shares | Ratio 0.50% | ▲0.10% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| NIPPON CHEMIPHAR CO.,LTD.4539 | Standard Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| TSUMURA & CO.4540 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Mid400 |
| KISSEI PHARMACEUTICAL CO.,LTD.4547 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 1 |
| SEIKAGAKU CORPORATION4548 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 2 |
| EIKEN CHEMICAL CO.,LTD.4549 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 1 |
| JCR Pharmaceuticals Co.,Ltd.4552 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 1 |
| TOWA PHARMACEUTICAL CO.,LTD.4553 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 1 |
| Fuji Pharma Co.,Ltd.4554 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 2 |
| CHUKYO IYAKUHIN CO.,LTD.4558 | Standard Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| ZERIA PHARMACEUTICAL CO.,LTD.4559 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 1 |